Breaking News
Investing Pro 0
Last Call for Cyber Monday! Save Now on Claim 60% OFF
Close

Novartis AG (NOVNz)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
84.895 +0.110    +0.13%
11:08:26 - Delayed Data. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Euro Zone
ISIN:  CH0012005267 
  • Volume: 69,191
  • Bid/Ask: 84.880 / 84.910
  • Day's Range: 84.525 - 84.965
Novartis 84.895 +0.110 +0.13%

NOVNz Income Statement

 
Featured here, the Income Statement (earnings report) for Novartis AG, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
30/09
2023
30/06
2023
31/03
2022
31/12
Total Revenue 12092 13936 13208 13087
Revenue 11782 13622 12953 12690
Other Revenue, Total 310 314 255 397
Cost of Revenue, Total 3089 4006 3829 3923
Gross Profit 9003 9930 9379 9164
Total Operating Expenses 8642 10239 9876 10021
Selling/General/Admin. Expenses, Total 3093 3673 3401 3699
Research & Development 2356 2394 2425 2360
Depreciation / Amortization 238 270 284 314
Interest Expense (Income) - Net Operating -222 -224 -211 -219
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 88 120 148 -56
Operating Income 3450 3697 3332 3066
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 96 -23 80 55
Other, Net 1802 951 512 1270
Net Income Before Taxes 1552 2769 2740 1741
Provision for Income Taxes 39 452 446 275
Net Income After Taxes 1513 2317 2294 1466
Minority Interest 81 84 83 81
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1511 2316 2293 1466
Total Extraordinary Items 250 - - -
Net Income 1761 2316 2293 1466
Total Adjustments to Net Income -250 - - -
Income Available to Common Excluding Extraordinary Items 1511 2316 2293 1466
Dilution Adjustment 246.25 -9.45 3.4 -17.69
Diluted Net Income 1514.75 2325.45 2289.6 1483.69
Diluted Weighted Average Shares 2075 2095 2120 2158
Diluted EPS Excluding Extraordinary Items 0.73 1.11 1.08 0.686
DPS - Common Stock Primary Issue - - - 3.46
Diluted Normalized EPS 0.984 1.07 0.954 0.839
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email